Study on Mucormycosis at a French University Hospital
Author Information
Author(s): Tom Cartau, Sylvain Chantepie, Angélique Thuillier-Lecouf, Bénédicte Langlois, Julie Bonhomme
Primary Institution: CHU de CAEN Normandie, France
Hypothesis
Understanding the epidemiology and clinical characteristics of mucormycosis could improve its management.
Conclusion
The study highlights the importance of early diagnosis and surgical intervention in improving outcomes for mucormycosis patients.
Supporting Evidence
- 18 cases of mucormycosis were identified over a decade.
- Most patients had hematological malignancies (89%).
- Surgical management was associated with a reduction in mortality (0% vs. 64%).
- The overall three-month mortality rate was 39%.
- PCR testing improved early diagnosis of mucormycosis.
Takeaway
Mucormycosis is a serious infection that can be treated better with quick diagnosis and surgery.
Methodology
A single-center retrospective study of all cases of mucormycosis observed over a decade.
Potential Biases
Potential bias due to the retrospective nature of the study and the specific patient population.
Limitations
The study is limited to a single center and may not represent broader trends.
Participant Demographics
Predominantly male patients (65%) with a median age of 64 years, mostly with hematological malignancies (89%).
Statistical Information
P-Value
0.013
Statistical Significance
p = 0.013
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website